There are some financial maneuvers that feel less like business strategy and more like a kind of corporate exorcism—a brutal, expensive ritual designed solely to extract value…
By Caroline Ashford ·
The constant, frantic dance of currency traders is never about the value of a dollar or a yen. It’s always about who gets to write the rules when the system inevitably stalls out.
By Maya Ellison ·
The whispers circulating about AstraZeneca and Bristol Myers Squibb—a potential merger valued at nearly $400 billion, as reported by CNBC, straitstimes.com, and others—are less an…
By Nikhil Raghavan ·